Hypofrontality in schizophrenic patients and its relevance for the choice of antipsychotic medication: An event-related potential study

References

• Abbruzzese M, Ferri S, Scarone S. 1997. The selective breakdown of frontal functions in patients with obsessive-compulsive disorder and in patients with schizophrenia: a double dissociation experimental finding. Neuropsychologia 35:907–912.
   PubMed Web of Science ®Google Scholar
• Abi-Dargham A, Laruelle M. 2005. Mechanisms of action of second generation antipsychotic drugs in schizophrenia: insights from brain imaging studies. Eur Psychiatry 20:15–27.
   PubMed Web of Science ®Google Scholar
• Allen DN, Goldstein G, Weiner C. 2001. Differential neuropsychological patterns of frontal- and temporal-lobe dysfunction in patients with schizophrenia. Schizophr Res 48:7–15.
   PubMed Web of Science ®Google Scholar
• Andreasen NC, O'Leary DS, Flaum M, Nopoulos P, Watkins GL, Boles Ponto LL . 1997. Hypofrontality in schizophrenia: distributed dysfunctional circuits in neuroleptic-naive patients. Lancet 349:1730–1734.
   PubMed Web of Science ®Google Scholar
• Berman I, Viegner B, Merson A, Allan E, Pappas D, Green AI. 1997. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia. Schizophr Res 25:1–10.
   PubMed Web of Science ®Google Scholar
• Braus DF, Ende G, Weber-Fahr W, Demirakca T, Tost H, Henn FA. 2002. Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia. Eur Neuropsychopharmacol 12:145–152.
   PubMed Web of Science ®Google Scholar
• Carter CS, MacDonald AW, 3rd, Ross LL, Stenger VA. 2001. Anterior cingulate cortex activity and impaired self-monitoring of performance in patients with schizophrenia: an event-related fMRI study. Am J Psychiatry 158:1423–1428.
   PubMed Web of Science ®Google Scholar
• Coull JT, Frith CD, Dolan RJ. 1999. Dissociating neuromo dulatory effects of diazepam on episodic memory encoding and executive function. Psychopharmacology (Berlin) 145: 213–222.
   PubMedGoogle Scholar
• de Bruijn ERA, Hulstijn W, Verkes RJ, Ruigt GSF, Sabbe BGC. 2004. Drug-induced stimulation and suppression of action monitoring in healthy volunteers. Psychopharmacology (Berlin) 177:151–160.
   PubMedGoogle Scholar
• Diaz-Mataix L, Scorza MC, Bortolozzi A, Toth M, Celada P, Artigas F. 2005. Involvement of 5-HT1A receptors in prefrontal cortex in the modulation of dopaminergic activity: role in atypical antipsychotic action. J Neurosci 25:10831–10843.
   PubMed Web of Science ®Google Scholar
• Ehlis AC, Zielasek J, Herrmann MJ, Ringel T, Jacob C, Fallgatter AJ. 2005a. Beneficial effect of atypical antipsychotics on prefrontal brain function in acute psychotic disorders. Eur Arch Psychiatry Clin Neurosci 255:299–307.
   PubMedGoogle Scholar
• Ehlis AC, Zielasek J, Herrmann MJ, Ringel T, Jacob C, Wagener A . 2005b. Evidence for unaltered brain electrical topography during prefrontal response control in cycloid psychoses. Int J Psychophysiol 55:165–178.
   PubMedGoogle Scholar
• Ehlis AC, Herrmann MJ, Pauli P, Stoeber G, Pfuhlmann B, Fallgatter AJ. 2007a. Improvement of prefrontal brain function in endogenous psychoses under atypical antipsychotic treatment. Neuropsychopharmacology 32:1669–1677.
   PubMedGoogle Scholar
• Ehlis AC, Reif A, Herrmann MJ, Lesch KP, Fallgatter AJ. 2007b. Impact of catechol-O-methyltransferase on prefrontal brain functioning in schizophrenia spectrum disorders. Neuropsychopharmacology 32:162–170.
   PubMed Web of Science ®Google Scholar
• Fallgatter AJ. 2001. Electrophysiology of the prefrontal cortex in healthy controls and schizophrenic patients: a review. J Neural Transm 108:679–694.
   PubMed Web of Science ®Google Scholar
• Fallgatter AJ, Brandeis D, Strik WK. 1997. A robust assessment of the NoGo-anteriorisation of P300 microstates in a cued Continuous Performance Test. Brain Topogr 9:295–302.
   PubMed Web of Science ®Google Scholar
• Fallgatter AJ, Mueller TJ, Strik WK. 1999. Age-related changes in the brain electrical correlates of response control. Clin Neurophysiol 110:833–838.
   PubMedGoogle Scholar
• Fallgatter AJ, Eisenack SS, Neuhauser B, Aranda D, Scheuerpflug P, Herrmann MJ. 2000. Stability of late event-related potentials: topographical descriptors of motor control compared with the P300 amplitude. Brain Topogr 12:255–261.
   PubMedGoogle Scholar
• Fallgatter AJ, Aranda DR, Bartsch AJ, Herrmann MJ. 2002a. Long-term reliability of electrophysiologic response control parameters. J Clin Neurophysiol 19:61–66.
   PubMed Web of Science ®Google Scholar
• Fallgatter AJ, Bartsch AJ, Herrmann MJ. 2002b. Electrophysiological measurements of anterior cingulate function. J Neural Transm 109:977–988.
   PubMed Web of Science ®Google Scholar
• Fallgatter AJ, Bartsch AJ, Zielasek J, Herrmann MJ. 2003. Brain electrical dysfunction of the anterior cingulate in schizophrenic patients. Psychiatry Res 124:37–48.
   PubMedGoogle Scholar
• Friedman L, Knutson L, Shurell M, Meltzer HY. 1991. Prefrontal sulcal prominence is inversely related to response to clozapine in schizophrenia. Biol Psychiatry 29:865–877.
   PubMed Web of Science ®Google Scholar
• Fuchs M, Kastner J, Wagner M, Hawes S, Ebersole JS. 2002. A standardized boundary element method volume conductor model. Clin Neurophysiol 113:702–712.
   PubMed Web of Science ®Google Scholar
• Glahn DC, Ragland JD, Abramoff A, Barrett J, Laird AR, Bearden CE . 2005. Beyond hypofrontality: a quantitative meta–analysis of functional neuroimaging studies of working memory in schizophrenia. Hum Brain Mapp 25:60–69.
   PubMed Web of Science ®Google Scholar
• Green MF, Kern RS, Heaton RK. 2004. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 72:41–51.
   PubMed Web of Science ®Google Scholar
• Honer WG, Smith GN, Lapointe JS, MacEwan GW, Kopala L, Altman S. 1995. Regional cortical anatomy and clozapine response in refractory schizophrenia. Neuropsychopharmacology 13:85–87.
   PubMedGoogle Scholar
• Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T. 1999. Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci USA 96:13432–13437.
   PubMed Web of Science ®Google Scholar
• Ichikawa J, Meltzer HY. 1999. Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs. Eur Arch Psychiatry Clin Neurosci 249(Suppl 4):90–98.
   PubMedGoogle Scholar
• Ichikawa J, Dai J, Meltzer HY. 2001. DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release. Brain Res 907:151–155.
   PubMedGoogle Scholar
• Ichikawa J, Chung Y-C, Dai J, Meltzer HY. 2005. Valproic acid potentiates both typical and atypical antipsychotic-induced prefrontal cortical dopamine release. Brain Res 1052: 56–62.
   PubMed Web of Science ®Google Scholar
• Ingvar DH, Franzen G. 1974. Distribution of cerebral activity in chronic schizophrenia. Lancet 2:1484–1486.
   PubMed Web of Science ®Google Scholar
• Jakab RL, Goldman-Rakic PS. 1998. 5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci USA 95:735–740.
   PubMed Web of Science ®Google Scholar
• Jurcak V, Tsuzuki D, Dan I. 2007. 10/20, 10/10, and 10/5 systems revisited: their validity as relative head-surface-based positioning systems. Neuroimage 34:1600–1611.
   PubMed Web of Science ®Google Scholar
• Kapur S, Remington G. 2001. Atypical antipsychotics: new directions and new challenges in the treatment of schizophrenia. Annu Rev Med 52:503–517.
   PubMed Web of Science ®Google Scholar
• Karow A, Naber D. 2002. Subjective well-being and quality of life under atypical antipsychotic treatment. Psychopharmacology (Berlin) 162:3–10.
   PubMed Web of Science ®Google Scholar
• Katz N, Tadmor I, Felzen B, Hartman-Maeir A. 2007. The Behavioural Assessment of the Dysexecutive Syndrome (BADS) in schizophrenia and its relation to functional outcomes. Neuropsychol Rehabil 17:192–205.
   PubMed Web of Science ®Google Scholar
• Keefe RS, Silva SG, Perkins DO, Lieberman JA. 1999. The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis. Schizophr Bull 25:201–222.
   PubMed Web of Science ®Google Scholar
• Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM . 2007. Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Arch Gen Psychiatry 64:633–647.
   PubMed Web of Science ®Google Scholar
• Kerns JG, Cohen JD, MacDonald AW 3rd, Johnson MK, Stenger VA, Aizenstein H . 2005. Decreased conflict- and error-related activity in the anterior cingulate cortex in subjects with schizophrenia. Am J Psychiatry 162:1833–1839.
   PubMed Web of Science ®Google Scholar
• Kreukels BPC, Schagen SB, Ridderinkhof KR, Boogerd W, Hamburger HL, van Dam FSAM. 2005. Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy. Breast Cancer Res Treat 94:53–61.
   PubMed Web of Science ®Google Scholar
• Kuroki T, Meltzer HY, Ichikawa J. 1999. Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. J Pharmacol Exp Ther 288: 774–781.
   PubMed Web of Science ®Google Scholar
• Lahti AC, Holcomb HH, Medoff DR, Weiler MA, Tamminga CA, Carpenter WT Jr. 2001. Abnormal patterns of regional cerebral blood flow in schizophrenia with primary negative symptoms during an effortful auditory recognition task. Am J Psychiatry 158:1797–1808.
   PubMed Web of Science ®Google Scholar
• Lahti AC, Holcomb HH, Weiler MA, Medoff DR, Frey KN, Hardin M . 2004. Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex. Neuropsychopharmacology 29:171–178.
   PubMed Web of Science ®Google Scholar
• Laurens KR, Ngan ET, Bates AT, Kiehl KA, Liddle PF. 2003. Rostral anterior cingulate cortex dysfunction during error processing in schizophrenia. Brain 126:610–622.
   PubMed Web of Science ®Google Scholar
• Lauriello J, Mathalon DH, Rosenbloom M, Sullivan EV, Faustman WO, Ringo DL . 1998. Association between regional brain volumes and clozapine response in schizophrenia. Biol Psychiatry 43:879–886.
   PubMedGoogle Scholar
• Lehmann D, Skrandies W. 1984. Spatial analysis of evoked potentials in man – a review. Prog Neurobiol 23:227–250.
   PubMed Web of Science ®Google Scholar
• Leucht S. 2007. Psychiatric treatment guidelines: doctors’ non-compliance or insufficient evidence? Acta Psychiatr Scand 115: 417–419.
   PubMedGoogle Scholar
• Meltzer HY, Matsubara S, Lee JC. 1989. The ratios of serotonin2 and dopamine2 affinities differentiate atypical and typical antipsychotic drugs. Psychopharmacol Bull 25:390–392.
   PubMed Web of Science ®Google Scholar
• Moghaddam B, Bunney BS. 1990. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. J Neurochem 54:1755–1760.
   PubMed Web of Science ®Google Scholar
• Mohamed S, Rosenheck R, Swartz M, Stroup S, Lieberman JA, Keefe RS. 2008. Relationship of cognition and psychopathology to functional impairment in schizophrenia. Am J Psychiatry 165:978–987.
   PubMed Web of Science ®Google Scholar
• Northoff G, Witzel T, Richter A, Gessner M, Schlagenhauf F, Fell J . 2002. GABA-ergic modulation of prefrontal spatio-temporal activation pattern during emotional processing: a combined fMRI/MEG study with placebo and lorazepam. J Cogn Neurosci 14:348–370.
   PubMed Web of Science ®Google Scholar
• Pascual-Marqui RD. 2002. Standardized low-resolution brain electromagnetic tomography (sLORETA): technical details. Methods Find Exp Clin Pharmacol 24(Suppl D):5–12.
   PubMed Web of Science ®Google Scholar
• Pehek EA, Yamamoto BK. 1994. Differential effects of locally administered clozapine and haloperidol on dopamine efflux in the rat prefrontal cortex and caudate-putamen. J Neurochem 63:2118–2124.
   PubMed Web of Science ®Google Scholar
• Priebe S, Gruyters T, Heinze M, Hoffmann C. 1995. Subjektive Evaluationskriterien in der psychiatrischen Versorgung – Ergebungsmethoden für Forschung und Praxis. Psychiatr Prax 22:140–144.
   PubMedGoogle Scholar
• Quintana SM, Maxwell SE. 1994. A Monte Carlo comparison of seven -adjustment procedures in repeated measures designs with small sample sizes. J Statist Educ 19:57–71.
   Google Scholar
• Rollema H, Lu Y, Schmidt AW, Sprouse JS, Zorn SH. 2000. 5-HT(1A) receptor activation contributes to ziprasidone-induced dopamine release in the rat prefrontal cortex. Biol Psychiatry 48:229–237.
   PubMed Web of Science ®Google Scholar
• Snitz BE, MacDonald A 3rd, Cohen JD, Cho RY, Becker T, Carter CS. 2005. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. Am J Psychiatry 162:2322–2329.
   PubMed Web of Science ®Google Scholar
• Stockmeier CA, DiCarlo JJ, Zhang Y, Thompson P, Meltzer HY. 1993. Characterization of typical and atypical antipsychotic drugs based on in vivo occupancy of serotonin2 and dopamine2 receptors. J Pharmacol Exp Ther 266:1374–1384.
   PubMed Web of Science ®Google Scholar
• Vaiva G, Cottencin O, Llorca PM, Devos P, Dupont S, Mazas O, . 2002. Regional cerebral blood flow in deficit/nondeficit types of schizophrenia according to SDS criteria. Prog Neuropsychopharmacol Biol Psychiatry 26:481–485.
   PubMed Web of Science ®Google Scholar
• Wacker J, Chavanon M-L, Leue A, Stemmler G. 2010. Trait BIS predicts alpha asymmetry and P300 in a Go/No-Go task. Eur J Pers 24:85–105.
   Google Scholar
• Weinberger DR, Lipska BK. 1995. Cortical maldevelopment, anti-psychotic drugs, and schizophrenia: a search for common ground. Schizophr Res 16:87–110.
   PubMed Web of Science ®Google Scholar
• Windischberger C, Lanzenberger R, Holik A, Spindelegger C, Stein P, Moser U, . 2010. Area-specific modulation of neural activation comparing escitalopram and citalopram revealed by pharmaco-fMRI: a randomized cross-over study. Neuroimage 49:1161–1170.
   PubMed Web of Science ®Google Scholar
• Woodward ND, Purdon SE, Meltzer HY, Zald DH. 2005. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia. Int J Neuropsychopharmacol 8:457–472.
   PubMed Web of Science ®Google Scholar